| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Emily J Cox, Neha Maharao, Gabriela Patilea-Vrana, Jashvant D Unadkat, Allan E Rettie, Jeannine S McCune, Mary F Pain. A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics. Pharmacology & therapeutics. vol 201. 2020-06-26. PMID:31071346. |
the popularity of these products highlights the relative absence of safety, pharmacokinetic, and drug interaction data for marijuana and its constituents, most notably the cannabinoids. |
2020-06-26 |
2023-08-13 |
Not clear |
| Emily J Cox, Neha Maharao, Gabriela Patilea-Vrana, Jashvant D Unadkat, Allan E Rettie, Jeannine S McCune, Mary F Pain. A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics. Pharmacology & therapeutics. vol 201. 2020-06-26. PMID:31071346. |
this review articulates current issues surrounding marijuana terminology, taxonomy, and dosing; summarizes cannabinoid pharmacology and pharmacokinetics; and assesses the drug interaction risks associated with co-consuming marijuana with conventional medications. |
2020-06-26 |
2023-08-13 |
Not clear |
| Giselle Castaneira, Kelley Rojas, Yehuda Galili, Zachary Field, Ariel Perez-Perez, Mario Madruga, Steve J Carla. Idiopathic Thrombocytopenic Purpura Induced by Synthetic Cannabinoid. Journal of addiction medicine. vol 13. issue 3. 2020-06-25. PMID:30531235. |
k2/spice, or synthetic marijuana, acts on cannabinoid receptors cb1 (cannabinoid type-1) and cb2 (cannabinoid type-2) with increased binding capacity compared to marijuana. |
2020-06-25 |
2023-08-13 |
Not clear |
| b' Zs\\xc3\\xb3fia K\\xc3\\xbcronya, Tam\\xc3\\xa1s Martin, Edina Kiss, Mih\\xc3\\xa1ly Sz\\xc5\\x91nyi, Krisztina B\\xc3\\xadr\\xc3\\xb. Using cannabis in oncology: facts and myths Orvosi hetilap. vol 161. issue 25. 2020-06-23. PMID:32516121.' |
the two most common cannabinoids are the strictly regulated psychotropic delta-9-tetrahydrocannabinol and the dietary supplement cannabidiol, which is non-psychoactive, only subject to reporting obligation and accessible in hungary since 2004. |
2020-06-23 |
2023-08-13 |
human |
| Michelle Sexto. Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence. Journal of alternative and complementary medicine (New York, N.Y.). vol 26. issue 6. 2020-06-22. PMID:32380847. |
cannabis in the time of coronavirus disease 2019: the yin and yang of the endocannabinoid system in immunocompetence. |
2020-06-22 |
2023-08-13 |
Not clear |
| Marie-Odile Krebs, Oussama Kebir, Therese M Ja. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders. European journal of pain (London, England). vol 23. issue 7. 2020-06-15. PMID:30793421. |
on the other hand, studies on the consequences of recreational use of cannabis and experimental studies bring some insights on the potential long-term consequences of cannabinoids use. |
2020-06-15 |
2023-08-13 |
Not clear |
| Piercarlo Sarzi-Puttini, Alberto Batticciotto, Fabiola Atzeni, Laura Bazzichi, Manuela Di Franco, Fausto Salaffi, Daniela Marotto, Angela Ceribelli, Jacob N Ablin, Winfred Hause. Medical cannabis and cannabinoids in rheumatology: where are we now? Expert review of clinical immunology. vol 15. issue 10. 2020-06-15. PMID:31512536. |
medical cannabis and cannabinoids in rheumatology: where are we now? |
2020-06-15 |
2023-08-13 |
Not clear |
| b' Simona Pichini, Giulio Mannocchi, Massimo Gottardi, Ana Pilar P\\xc3\\xa9rez-Acevedo, Lourdes Poyatos, Esther Papaseit, Clara P\\xc3\\xa9rez-Ma\\xc3\\xb1\\xc3\\xa1, Mag\\xc3\\xad Farr\\xc3\\xa9, Roberta Pacifici, Francesco Paolo Busard\\xc3\\xb. Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual. Talanta. vol 209. 2020-06-08. PMID:31892011.' |
fast and sensitive uhplc-ms/ms analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual. |
2020-06-08 |
2023-08-13 |
Not clear |
| Lutfun Nahar, Alev Onder, Satyajit D Sarke. A review on the recent advances in HPLC, UHPLC and UPLC analyses of naturally occurring cannabinoids (2010-2019). Phytochemical analysis : PCA. vol 31. issue 4. 2020-06-05. PMID:31849137. |
organic molecules that bind to cannabinoid receptors are called cannabinoids, and they have similar pharmacological properties like the plant, cannabis sativa l. hyphenated liquid chromatography (lc), incorporating high-performance liquid chromatography (hplc) and ultra-performance liquid chromatography (uplc, also known as ultrahigh-performance liquid chromatography, uhplc), usually coupled to an ultraviolet (uv), uv-photodiode array (pda) or mass spectrometry (ms) detector, has become a popular analytical tool for the analysis of naturally occurring cannabinoids in various matrices. |
2020-06-05 |
2023-08-13 |
Not clear |
| Juste Baranauskaite, Mindaugas Marksa, Liudas Ivanauskas, Konradas Vitkevicius, Mindaugas Liaudanskas, Vaidas Skyrius, Algirdas Baranauska. Development of extraction technique and GC/FID method for the analysis of cannabinoids in Cannabis sativa L. spp. santicha (hemp). Phytochemical analysis : PCA. vol 31. issue 4. 2020-06-05. PMID:31943398. |
development of extraction technique and gc/fid method for the analysis of cannabinoids in cannabis sativa l. spp. |
2020-06-05 |
2023-08-13 |
Not clear |
| Julieta Lazarte, Robert A Hegel. Cannabis effects on lipoproteins. Current opinion in lipidology. vol 30. issue 2. 2020-06-04. PMID:30649023. |
a family of endocannabinoid receptors is susceptible to cannabis constituents. |
2020-06-04 |
2023-08-13 |
Not clear |
| Daniel Friedman, Jacqueline A French, Mauro Maccarron. Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders. The Lancet. Neurology. vol 18. issue 5. 2020-06-04. PMID:30910443. |
despite positive results in these two severe epilepsy syndromes, further studies are needed to determine if the anti-seizure effects of cannabidiol extend to other forms of epilepsy, to overcome pharmacokinetic challenges with oral cannabinoids, and to uncover the exact mechanisms by which cannabidiol or other exogenous and endogenous cannabinoids exert their therapeutic effects. |
2020-06-04 |
2023-08-13 |
Not clear |
| Hina Akram, Claire Mokrysz, H Valerie Curra. What are the psychological effects of using synthetic cannabinoids? A systematic review. Journal of psychopharmacology (Oxford, England). vol 33. issue 3. 2020-05-27. PMID:30789300. |
synthetic cannabinoids are, typically, full agonists at the cannabinoid cb1 receptor, and therefore considerably more potent than natural cannabis and may have correspondingly more serious psychological effects. |
2020-05-27 |
2023-08-13 |
Not clear |
| Gabriela I Patilea-Vrana, Jashvant D Unadka. Quantifying Hepatic Enzyme Kinetics of (-)-∆ Drug metabolism and disposition: the biological fate of chemicals. vol 47. issue 7. 2020-05-27. PMID:31048453. |
quantifying hepatic enzyme kinetics of (-)-∆ the prevalence of cannabis use and the concentrations of the psychoactive cannabinoid in cannabis, (-)-∆ |
2020-05-27 |
2023-08-13 |
Not clear |
| Joel Ehrenkranz, Michael A Levin. Bones and Joints: The Effects of Cannabinoids on the Skeleton. The Journal of clinical endocrinology and metabolism. vol 104. issue 10. 2020-05-27. PMID:31393556. |
with the increasing use of endocannabinoid mimetics (e.g., tetrahydrocannabinol and cannabidiol), the involvement of endocannabinoids in bone growth and remodeling has become clinically relevant. |
2020-05-27 |
2023-08-13 |
Not clear |
| Rebeca Olivia Millán-Guerrero, Sara Isais-Millá. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies. Gaceta medica de Mexico. vol 155. issue 5. 2020-05-22. PMID:32091020. |
cannabis and the exocannabinoid and endocannabinoid systems. |
2020-05-22 |
2023-08-13 |
Not clear |
| Rebeca Olivia Millán-Guerrero, Sara Isais-Millá. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies. Gaceta medica de Mexico. vol 155. issue 5. 2020-05-22. PMID:32091020. |
the primary cannabinoids that have been studied to date include cannabidiol and delta-9-tetrahydrocannabinol, which is responsible for most cannabis physical and psychotropic effects. |
2020-05-22 |
2023-08-13 |
Not clear |
| Rebeca Olivia Millán-Guerrero, Sara Isais-Millá. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies. Gaceta medica de Mexico. vol 155. issue 5. 2020-05-22. PMID:32091020. |
some studies suggest cannabidiol has great potential for therapeutic use as an agent with antiepileptic, analgesic, anxiolytic, antipsychotic, anti-inflammatory and neuroprotective properties; however, the findings on cannabinoids efficacy and cannabis-based medications tolerability-safety for some conditions are inconsistent. |
2020-05-22 |
2023-08-13 |
Not clear |
| Shaul Schreiber, Miaad Bader, Tatiana Lenchinski, Inbar Meningher, Vardit Rubovitch, Yiffat Katz, Etia Cohen, Yankel Gabet, Michal Rotenberg, Ehud Udi Wolf, Chaim G Pic. Functional effects of synthetic cannabinoids versus Δ Addiction biology. vol 24. issue 3. 2020-05-18. PMID:29423994. |
functional effects of synthetic cannabinoids versus Δ synthetic cannabinoids are psychoactive substances designed to mimic the euphorigenic effects of the natural cannabis. |
2020-05-18 |
2023-08-13 |
Not clear |
| Geraint Berger, Nipun Arora, Ian Burkovskiy, Yanfang Xia, Anu Chinnadurai, Robert Westhofen, Georg Hagn, Ashley Cox, Melanie Kelly, Juan Zhou, Christian Lehman. Experimental Cannabinoid 2 Receptor Activation by Phyto-Derived and Synthetic Cannabinoid Ligands in LPS-Induced Interstitial Cystitis in Mice. Molecules (Basel, Switzerland). vol 24. issue 23. 2020-05-13. PMID:31766439. |
this study used intravital microscopy (ivm) and behavioral testing in lipopolysaccharide-induced ic, to investigate the anti-inflammatory analgesic effects of a natural dietary sesquiterpenoid, beta-caryophyllene (bcp), which is present in cannabis among other plants, and has reported agonist actions at the cannabinoid 2 receptor (cb |
2020-05-13 |
2023-08-13 |
mouse |